Chatterjee N - Search Results

1

Developing and evaluating polygenic risk prediction models for stratified disease prevention.

Chatterjee N, Shi J, García-Closas M. Chatterjee N, et al. Nat Rev Genet. 2016 Jul;17(7):392-406. doi: 10.1038/nrg.2016.27. Epub 2016 May 3. Nat Rev Genet. 2016. PMID: 27140283 Free PMC article. Review.

2

The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.

Rutter JL, Chatterjee N, Wacholder S, Struewing J. Rutter JL, et al. Among authors: chatterjee n. Epidemiology. 2003 Nov;14(6):694-700. doi: 10.1097/01.ede.0000083227.74669.7b. Epidemiology. 2003. PMID: 14569185

3

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP. Sigurdson AJ, et al. Among authors: chatterjee n. BMC Cancer. 2004 Mar 12;4:9. doi: 10.1186/1471-2407-4-9. BMC Cancer. 2004. PMID: 15113441 Free PMC article.

4

Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.

Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, Colt J, Goldin L, Severson RK. Chatterjee N, et al. Cancer Epidemiol Biomarkers Prev. 2004 Sep;13(9):1415-21. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15342441

5

Methods for testing familial aggregation of diseases in population-based samples: application to Hodgkin lymphoma in Swedish registry data.

Pfeiffer RM, Goldin LR, Chatterjee N, Daugherty S, Hemminki K, Pee D, X LI, Gail MH. Pfeiffer RM, et al. Among authors: chatterjee n. Ann Hum Genet. 2004 Sep;68(Pt 5):498-508. doi: 10.1046/j.1529-8817.2003.00111.x. Ann Hum Genet. 2004. PMID: 15469426

6

Exploiting gene-environment independence in family-based case-control studies: increased power for detecting associations, interactions and joint effects.

Chatterjee N, Kalaylioglu Z, Carroll RJ. Chatterjee N, et al. Genet Epidemiol. 2005 Feb;28(2):138-56. doi: 10.1002/gepi.20049. Genet Epidemiol. 2005. PMID: 15593088

7

CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.

Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, Bresalier RS, Chanock SJ, Caporaso NE, Ji BT, Weissfeld JL, Hayes RB. Hou L, et al. Among authors: chatterjee n. Carcinogenesis. 2005 Jun;26(6):1122-8. doi: 10.1093/carcin/bgi054. Epub 2005 Feb 24. Carcinogenesis. 2005. PMID: 15731166

8

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N. García-Closas M, et al. Among authors: chatterjee n. Lancet. 2005 Aug 20-26;366(9486):649-59. doi: 10.1016/S0140-6736(05)67137-1. Lancet. 2005. PMID: 16112301 Free PMC article.

9

A prospective study of lycopene and tomato product intake and risk of prostate cancer.

Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB. Kirsh VA, et al. Among authors: chatterjee n. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):92-8. doi: 10.1158/1055-9965.EPI-05-0563. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434593

10

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.

Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U; PLCO Trial. Kirsh VA, et al. Among authors: chatterjee n. J Natl Cancer Inst. 2006 Feb 15;98(4):245-54. doi: 10.1093/jnci/djj050. J Natl Cancer Inst. 2006. PMID: 16478743

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results